国际妇产科学杂志

国际妇产科学杂志 ›› 2017, Vol. 44 ›› Issue (1): 18-22.

• 综述 • 上一篇    下一篇

卵巢交界性肿瘤的诊疗现状

李爽1,史小荣2,成思蓉1,孟霖3   

  1. 1. 山西医科大学第一临床医学院
    2. 山西医科大学第一医院
    3. 中国农业科学院烟草研究所
  • 收稿日期:2016-10-10 修回日期:2016-11-21 出版日期:2017-02-15 发布日期:2017-03-28
  • 通讯作者: 史小荣 E-mail:shixiaorong135@163.com

Current status of diagnosis and treatment of borderline ovarian tumors

  • Received:2016-10-10 Revised:2016-11-21 Published:2017-02-15 Online:2017-03-28

PDF (PC)

9885

摘要： 摘要：卵巢交界性肿瘤（borderline ovarian tumor,BOT）是一种低度恶性潜能的卵巢肿瘤，具有发病年龄轻、早期发现、预后好的特点，但术前诊断困难，虽然血清肿瘤标志物、盆腔超声及术中快速冰冻病理切片可协助诊断，但准确率不高。近年来，BOT的手术治疗方式逐渐由根治性手术向保留生育功能的手术转变。然而，关于其早期诊断、手术方式的选择及预后等问题一直存在广泛争议，本文就BOT诊断、治疗的研究现状进行综述，以期为今后BOT的临床诊疗及新的诊疗技术研究提供参考。

关键词: 关键词：卵巢交界性肿瘤, 诊断, 治疗, 预后

Abstract: Abstract：Borderline ovarian tumors (BOT) is a low malignant potential ovarian tumors，it has the characteristics of early onset, early detection and good prgnosis, but the preoperative diagnosis is difficult. Although the serum tumor markers, pelvic ultrasound and intraoperative frozen biopsy could assist the diagnosis, but the accuracy is low. In recent years, the surgical treatment of BOT gradually changed from radical operation to fertility preserving surgery. However, there has been widespread controversy about its early diagnosis, therapy and prognosis, this article reviews the research status of BOT diagnosis and treatment, in order to provide references for the clinical diagnosis and treatment of BOT and new treatment technology research.

Key words: Key words：Borderline ovarian tumor, Diagnosis, Therapy, Prognosis